Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Garweg, JG"'
Publikováno v:
Clinical Ophthalmology, Vol Volume 16, Pp 2235-2243 (2022)
Juliana Wons,1 Isabel B Pfister,1,2 Stefano Anastasi,1 Sonja Steinhauer,1 Sophie-Alexia Niderprim,3 Justus G Garweg1,2,4 1Clinic for Vitreoretinal Disease, Berner Augenklinik, Bern, Switzerland; 2Swiss Eye Institute, Rotkreuz, Switzerland; 3Ophthalmo
Externí odkaz:
https://doaj.org/article/e97c40eb3077466192d297f0815790f4
Publikováno v:
Clinical Ophthalmology, Vol Volume 15, Pp 1851-1860 (2021)
Juliana Wons,1,* Nadine Mihic,2,* Isabel B Pfister,1 Stefano Anastasi,1 Justus G Garweg,1,2 Markus Halberstadt3 1Swiss Eye Institute, Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 2Department of Ophthalmology, University of
Externí odkaz:
https://doaj.org/article/b5bdacf6ec5541adb9abf95da157be18
Publikováno v:
Clinical Ophthalmology, Vol Volume 14, Pp 4493-4500 (2020)
Mario Deiss,1,* Cagdas Kaya,2,3,* Isabel B Pfister,2,3 Justus G Garweg1– 4 1University of Bern, Bern, Switzerland; 2Swiss Eye Institute, Rotkreuz, Switzerland; 3Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 4Department of Ophthalmology,
Externí odkaz:
https://doaj.org/article/ee799a58741241d5a184935da2a5cf9f
Publikováno v:
Clinical Ophthalmology, Vol Volume 14, Pp 299-305 (2020)
Justus G Garweg,1,2 Dean Ouassi,3 Isabel B Pfister1 1Swiss Eye Institute and Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 2Department of Ophthalmology, Inselspital, Bern, Switzerland; 3Medical Faculty, University of Strasbourg, Strasbour
Externí odkaz:
https://doaj.org/article/291a614b6c0048b9bce1486cb91fb9d1
Publikováno v:
Clinical Ophthalmology, Vol Volume 13, Pp 2403-2409 (2019)
Cagdas Kaya,1 Souska Zandi,1,3 Isabel B Pfister,1,2 Christin Gerhardt,1,2 Justus G Garweg1,2 1Swiss Eye Institute, Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 2Department Ophthalmology, University Hospital Bern, Bern, Swit
Externí odkaz:
https://doaj.org/article/6edd1de197354931b6da13e16e01058e
Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
Autor:
Garweg JG
Publikováno v:
Clinical Ophthalmology, Vol Volume 13, Pp 1289-1295 (2019)
Justus G Garweg1,21Swiss Eye Institute, Rotkreuz, and Berner Augenklinik Am Lindenhofspital, Bern, Switzerland; 2Department of Ophthalmology, Inselspital, University of Bern, Bern, SwitzerlandPurpose: To review published evidence for a treatment inte
Externí odkaz:
https://doaj.org/article/261e998235554db1a3605447656a0880
Publikováno v:
33. Jahrestagung der Retinologischen Gesellschaft; 20210625-20210626; München (digital); DOC21rg32 /20210624/
Hintergrund: VIOLET schloss Patienten mit diabetischem-Makulaödem (DMÖ) ein, die bereits 1 Jahr intravitreales Aflibercept 2mg (IVT-AFL) behandelt erhielten. Primäres Ziel war die Untersuchung, ob zwei flexible IVT-AFL-Regime (Treat-and-Extend [T&
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eaeeaae13bc282727aec91e87ce23a1
Autor:
Garweg, Jg, Stefanickova, J, Hoyng, C, Schmelter, T, Niesen, T, Sowade, O, Sivaprasad, S, Adan, A, Alexik, M, Ali, F, Amaro, M, Balciuniene, V, Bandello, Fm, Arias Barquet, L, Beck, A, Bell, K, Boscia, F, Bures, A, Carneiro, A, Chow, Dr, Cimbalas, A, Dahlke, C, Deepali, V, Dickinson, Jd, Dollin, M, Eandi, C, Emmerich, K, Feltgen, N, Pereira Figueira, J, Findl, O, Gajdosova, M, Gale, Rp, John Galic, I, Garweg, J, Gasser-Steiner, V, Giunta, M, Gonder, Jr, Grzybowski, A, Hamouz, J, Hattenbach, L, Holz, Fg, Jesia, H, Kaluzny, J, Kerenyi, A, Kertes, Pj, Koch, F, Kodjikan, L, Lederer, De, Liehneova, I, Lorenz, K, Lotery, Aj, Mckibbin, M, Menon, Gv, Michalewska, Z, Midena, E, Nicolo, M, Papp, A, Pavlovicova, G, Peiretti, E, Vaz-Pereira, S, Perri, P, Petropoulos, I, Queguiner, F, Raczynska, K, Sararols-Ramsay, L, Rekas, M, Ricci, F, Romanowska-Dixon, B, Sachs, Hg, Mohand-Said, S, Sandner, D, Schmidt-Erfurth, U, Sekundo, W, Seres, A, Souied, E, Castro de Sousa, J, Stankiewicz, A, Struharova, K, Studnicka, J, Cervera Taulet, E, Taylor, S, Teper, S, Vajas, A, Cava Valenciano, C, Varsanyi, B, Viola, F, Virgili, G, Wagenfeld, L, Walters, G, Wiedemann, P, Zarnowski, T
Purpose: To examine vision-related quality of life in patients with diabetic macular edema (DME) treated with intravitreal aflibercept (EYLEA, Regeneron Pharmaceuticals, Inc, Tarrytown, NY). Design: AQUA was a multicenter, open-label, single-arm, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::11a401a9bb009904e1d904a0afe1d8d3
Autor:
Garweg Jg
Publikováno v:
Der Ophthalmologe. 113:1036-1045
Background Current understanding of the mechanisms that underlie the long-term consequences of anti-VEGF therapy in wet, age-related macular degeneration (AMD) is poor. Here, the impact of this treatment on the development of macular atrophy (MA) is
Publikováno v:
Eye
Eye, Nature Publishing Group: Open Access Hybrid Model Option B, 2009, 23, pp.1469-1492
Eye, 2009, 23, pp.1469-1492
Eye, Nature Publishing Group: Open Access Hybrid Model Option B, 2009, 23, pp.1469-1492
Eye, 2009, 23, pp.1469-1492
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af1eb2b2ca73a1b97fc6a6048061a67f
https://hal.archives-ouvertes.fr/hal-00539433
https://hal.archives-ouvertes.fr/hal-00539433